Skip to main content
Premium Trial:

Request an Annual Quote

RenalytixAI Receives Approval From New York State to Offer Kidney Test

NEW YORK – Kidney disease diagnostics firm RenalytixAI announced Friday it has received a clinical laboratory permit from the New York State Department of Health allowing the company to provide its KidneyIntelX test to residents of the state.

The test can now be used to report risk assessment results for fast-progressing kidney disease and future kidney failure for patients with Type 2 diabetes and chronic kidney disease. KidneyIntelX is meant to be used with clinical evaluation to help in the risk assessment of progressive kidney function decline within five years.

A panel of DOH scientists and external reviewers conducted a review of the test's analytical and clinical validation results and NYSDOH officials inspected the firm's New York laboratory before granting the permit. The approval is effective immediately and has been granted for an indefinite period, but it is subject to compliance with state standards and can be withdrawn in the case of non-compliance.

The London-based artificial intelligence company said it will now move to complete KidneyIntelX's full commercial launch with Mount Sinai Health System and will likely start reporting patient results in the third quarter of 2020. A recent study found the test can identify patients at the highest risk of progressive decline in kidney function in early-stage diabetic kidney disease with higher accuracy than current methods.

In April, RenalytixAI partnered with Mount Sinai for a clinical study to analyze biomarkers to predict major adverse kidney events in patients hospitalized with COVID-19.

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.